New 'Lock-and-Key' Chemistry Could Improve Cancer Treatments

Syracuse University researchers develop a strategy to keep cancer drugs dormant until they reach tumor cells.

Published on Feb. 26, 2026

Got story updates? Submit your updates here. ›

Many cancer treatments are highly toxic, often harming healthy tissues and causing significant side effects. Researchers at Syracuse University have introduced a "lock-and-key" system that holds therapeutic drugs in an inactive, caged form until a separate chemical trigger releases them at a specific site, like a tumor. This biorthogonal chemistry approach could improve treatment precision and reduce side effects from drugs acting in the wrong places.

Why it matters

Current cancer treatments often fail because they damage healthy tissues. Chemotherapy drugs circulate throughout the body, leading to severe side effects. A system that allows drugs to remain inactive until they reach the disease site could help eliminate that collateral damage and improve the effectiveness of cancer therapies.

The details

The new system uses biorthogonal supramolecular chemistry, where a "host" molecule recognizes and connects with a complementary "guest" partner in a highly selective manner. This interaction acts as the "key" to release the drug from its inactive, caged form. In cell-based experiments, the researchers were able to control the release of different cancer-therapeutic agents and dial cancer cell killing up or down, suggesting new possibilities for better controlled therapies.

  • The study was published in Angewandte Chemie International Edition in February 2026.

The players

Xiaoran Hu

An assistant professor of chemistry in the College of Arts & Sciences at Syracuse University, who led the research team that developed the new "lock-and-key" chemistry system.

Syracuse University

The university where the research was conducted and published.

Got photos? Submit your photos here. ›

What they’re saying

“We are developing a broadly applicable tool that has the potential to regulate the activity of different types of therapeutics. Think of this as a tool, like a hammer, that could be used on different nails.”

— Xiaoran Hu, Assistant Professor of Chemistry (Angewandte Chemie International Edition)

“Our drug-activation chemistry can be conducted in complex biological environments and does not perturb native biomolecules and cellular processes. In the future, this process could improve treatment precision and reduce side effects from drugs acting in the wrong places.”

— Xiaoran Hu, Assistant Professor of Chemistry (Angewandte Chemie International Edition)

What’s next

Future research will aim to strengthen the locking interactions between the "host" and "guest" molecules so that the drug stays inactive while circulating and only activates when triggered, improving the stability and effectiveness of the system under physiological conditions.

The takeaway

This new "lock-and-key" chemistry platform represents a promising strategy to improve the precision and safety of cancer treatments by keeping drugs dormant until they reach the tumor site, potentially reducing harmful side effects on healthy tissues.